European Medicines Agency - Regulatory - Regulation of medicines

5 -Training and educational capacity to build competencies



    Description

Name

 

ECFS-CTN - European Cystic Fibrosis Society - Clinical Trials Network

Evidence of collaboration with regulatory authorities Yes ECFS-CTN is in discussion with EMA regarding the specific guidelines for cystic fibrosis clinical trials (workshop on endpoints for cystic fibrosis clinical trials European Medicines Agency, London, 27-28 September 2012) http://www.ema.europa.eu/docs/en_GB/document_library/Report/2012/12/WC500136159.pdf A similar workshop was conducted 08Dec2015 to discuss gastrointestinal endpoints http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2015/11/event_detail_001241.jsp&mid=WC0b01ac058004d5c3
Capacity to provide competent consultation to regulatory authorities Yes see above
Formal meetings for clinical trials No Are organized by the pharma company or academic sponsor
Training courses given over the last 2 years Yes 5 (yearly training day for ECFS-CTN investigators and research coordinators, at the ECFS conference in June)
Training courses received over the last 2 years Yes idem as above
Promotion of participation in clinical trials in countries with limited resources No
List of Countries